A multicenter, non-interventional study to evaluate the disease activity in Multiple Sclerosis after withdrawal of Natalizumab in Portugal-Reference-Cited by-同舟云学术

A multicenter, non-interventional study to evaluate the disease activity in Multiple Sclerosis after withdrawal of Natalizumab in Portugal

Published:2019-09 Issue: Volume:184 Page:105390
ISSN:0303-8467
Container-title:Clinical Neurology and Neurosurgery
language:en
Short-container-title:Clinical Neurology and Neurosurgery

Author:

Ladeira Filipa,Braz Luís,Salgado Paula,Vaz Soraia,Leitão Lia,Félix Catarina,Correia Ana Sofia,Silva Ana Martins da,Salgado Vasco,Ferreira Fátima,Vale José,Sá Maria José de,Capela Carlos

Publisher

Elsevier BV

Subject

Clinical Neurology,General Medicine,Surgery

Reference30 articles.

1. Natalizumab: a review of its use in the management of relapsing-remitting multiple sclerosis;McCormack;Drugs,2013

2. Disease activity return after natalizumab cessation in multiple sclerosis;Rasenack;Expert Rev. Neurother.,2016

3. Post-natalizumab clinical and radiological findings in a cohort of multiple sclerosis patients: 12-month follow-up;Melis;Neurol. Sci.,2014

4. Relapse frequency in transitioning from natalizumab to dimethyl fumarate: assessment of risk factors;Zurawski;J. Neurol.,2016

5. Risk of relapse after natalizumab withdrawal - results from the French TYSEDMUS cohort;Papeix;Neurol. Neuroimmunol. Neuroinflamm.,2016

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Multiple faces of multiple sclerosis in the era of highly efficient treatment modalities: Lymphopenia and switching treatment options challenges daily practice;International Immunopharmacology;2023-12

2. Systematic Review and Meta-Analysis Comparing the Safety of Natalizumab, Ocrelizumab, and Alemtuzumab in Treating Relapsing–Remitting, Primary Progressive, and Secondary Progressive Multiple Sclerosis;Journal of Pharmacology and Pharmacotherapeutics;2022-03

3. Neuroinflammatory Regulation of Gold Nanoparticles Conjugated to Ethylene Dicysteine Diethyl Ester in Experimental Autoimmune Encephalomyelitis;ACS Biomaterials Science & Engineering;2021-02-15

4. Disease-Modifying Drugs and Family Planning in People with Multiple Sclerosis: A Consensus Narrative Review from the Gulf Region;Neurology and Therapy;2020-06-20